Skip to main content
. 2020 Oct;9(5):2082–2096. doi: 10.21037/tlcr-20-512

Figure 1.

Figure 1

Consideration of the optimal choice of systematic drugs for unresectable locally advanced non-small cell lung cancer (LA-NSCLC). GC, glucocorticoid; ICIs, Immune checkpoint inhibitors; CCRT, concurrent chemo-radiotherapy; PD-1, programmed cell death-1; PD-L1, programmed cell death ligand 1.